latest news releases from the newsroom
NexHorizon Communications, Inc.
NexHorizon Joint Ventures With Specific Media to Boost Advertising Sales
WESTMINSTER, Colo., July 8, 2009 (GLOBE NEWSWIRE) -- NexHorizon Communications, Inc. (Pink Sheets:NXHZ) (www.nexhorizon.us) today announced it has entered into a joint venture with Praebius Communications, Inc. (Pink Sheets:PRCM) Specific Media Group, to develop advertising revenues. The joint venture will focus on the development of advertising sales revenues, including university installations serving well over 100,000 students, with over 23,000 thirty second spots per university campus on the top cable TV networks.
Neah Power Systems, Inc.
NEAH Creates the First Hybrid Electrolyte Aerobic Direct Methanol Fuel Cell
BOTHELL, Wash., July 8, 2009 (GLOBE NEWSWIRE) -- NEAH Power Systems, Inc. (OTCBB:NPWS), the Company developing fuel cells for the military and portable electronic devices, announced today that it has achieved yet another major breakthrough with the demonstration of an air based fuel cell for aerobic applications. This system, when fully developed, is expected to have higher energy density than any incumbent direct methanol anaerobic fuel cell available today, and could enable NEAH to pursue various additional consumer markets.
PSS World Medical to Broadcast Its Fiscal 2010 First Quarter Conference Call Live On the Internet
JACKSONVILLE, Fla., July 8, 2009 (GLOBE NEWSWIRE) -- PSS World Medical, Inc. (Nasdaq:PSSI) today announced that it will provide an online Web simulcast of its fiscal 2010 first quarter conference call on Thursday, July 23, 2009. The Company's financial results for the first quarter ended June 26, 2009, will be released after the close of market trading on Wednesday, July 22, 2009.
PricewaterhouseCoopers Names John Verderese U.S. Advisory Services Talent Management Leader
NEW YORK, July 8, 2009 (GLOBE NEWSWIRE) -- PricewaterhouseCoopers LLP (PwC) today announced that John Verderese has been appointed leader of the firm's U.S. Advisory Services Talent Management group. In this role, Mr. Verderese will leverage his significant human capital and human resource transformation experience to help drive the strategy, direction and growth of the firm's Talent Management services within the People and Change practice.
Foresight Biotherapeutics Announces FST-100 Displays Robust Clinical Improvement in Adenoviral Conjunctivitis Model
NEW YORK, July 8, 2009 (GLOBE NEWSWIRE) -- Foresight Biotherapeutics, Inc. today announced data from a pre-clinical study designed to assess the safety and efficacy of the topical administration of FST-100 in a highly regarded Ad5 NZW rabbit model of adenoviral conjunctivitis. FST-100 demonstrated a clinically and statistically significant reduction in signs of adenoviral conjunctivitis versus all other groups including the current experimental "gold standard" topical cidofovir. The study was conducted at the Louisiana State University (LSU) Health Science Center, LSU Eye Center in New Orleans, Louisiana by Professor James M. Hill and colleagues, in the Departments of Pharmacology, Microbiology, Ophthalmology and Neuroscience.